Products
Incandiga Extended Release Film Coated Tablets
| Therapeutic Category | SGLT2 Inhibitor + Biguanide (Antidiabetic) |
|---|---|
| Main Ingredient(s) | Dapagliflozin + Metformin (10/500 mg, 5/1000 mg, 10/1000 mg) |
| Dosage Form | Extended Release Film Coated Tablet |
| Description | Fixed-dose combination for adults with type 2 diabetes. |
| Target Use / Indication | Type 2 Diabetes Mellitus (Adults) |
| Key Benefits | Combines two complementary agents for blood glucose control in one extended release tablet. |